NEW YORK, April 24, 2015 (GLOBE NEWSWIRE) -- Pomerantz LLP and The Rosen Law Firm, P.A., hereby announce that the United States District Court for the District of Oregon has approved the following announcement concerning defendants Milla Bjorn a/k/a Kamilla Bjorlin and Lidingo LLC in the shareholder class action against Galena Biopharma, Inc. (GALE).
UNITED STATES DISTRICT COURT
DISTRICT OF OREGON
IN RE GALENA BIOPHARMA, INC SECURITIES LITIGATION
CASE No.:3-14-cv-00367-SI
TO: MILLA BJORN A/K/A KAMILLA BJORLIN AND LIDINGO LLC
A lawsuit has been filed against you. Within 21 days of the date of first publication specified herein you must serve on the plaintiff an answer to the attached complaint or a motion under Rule 12 of the Federal Rules of Civil Procedure. The answer or motion must be served on the plaintiff or plaintiff's attorney, whose name and address are:
Patrick V. Dahlstrom
Pomerantz LLP
10 South LaSalle Street, Suite 3505
Chicago, IL 60603
Phone: 312-377-1181
If you have questions, you should see an attorney immediately. If you need help in finding an attorney, you may contact the Oregon State Bar's Lawyer Referral Service online at www.oregonstatebar.org or by calling (503) 684-3763 (in the Portland metropolitan area) or toll-free elsewhere in Oregon at (800) 452-7636.
This is a securities class action on behalf of a class consisting of all persons who purchased or otherwise acquired Galena's common stock between August 6, 2013 and May 14, 2014, inclusive, seeking money damages in an amount to be determined at trial.
Summons first published: April 10, 2015
[SIGNED] MARY L. MORAN, Clerk of Court By:/ C. Brost, Deputy Clerk
BY ORDER OF THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF OREGON